Centers for Medicare & Medicaid Services (CMS) and its contractor, Acumen, LLC, will be conducting field testing for eight episode-based cost measures before consideration of their potential use in the cost performance category of the Merit-based Incentive Payment System (MIPS) of the Quality Payment Program. Please note that this field testing of new cost measures is separate from measures reported in the Quality and Resource Use Reports (QRURs), which you may also be receiving around the same time.

Field testing will take place from October 16 to November 15, 2017. During this time, clinicians and clinician groups (TINs) who are attributed episodes for performing or managing the procedures/medical conditions listed below will have the opportunity to view a confidential report with information about their performance. In addition, all stakeholders will be able to view a mock report and supplemental documentation on the measures that will be publicly posted. Therefore, we will be seeking feedback from all stakeholders on the measures, confidential or mock report, and supplemental documentation through an online survey.

The episode-based cost measures, which will be reported during field testing to group practices and solo practitioners who meet a 10-episode case minimum for at least one measure during the measurement period of 06/01/16 to 05/31/17, are the following:

Below, we provide an overview of the policy background, measure development process, and details of field testing activities. Please feel free to share this message with anyone you believe may be interested in these activities.

Policy Background

The Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization Act of 2015 (MACRA) introduced a new approach to clinician payment called the Quality Payment Program. This program rewards the delivery of high-quality patient care through Advanced Alternative Payment Models (Advanced APMs) and MIPS. The measures we are developing under this project are for potential use in the cost performance category, one of four performance categories being used in MIPS.

Summary of Measure Development Process so Far

The measure development process for these new episode-based cost measures for potential use in MIPS involves extensive clinician involvement and stakeholder feedback. It also builds on various public postings for CMS’s previous cost measure development work, the most recent of which was the posting of a draft list of episode groups and trigger codes in December 2016. These earlier episode group postings are available on the CMS MACRA feedback page.

Eight measures were selected and developed with extensive input from Clinical Subcommittees and informed by input received through a Technical Expert Panel and past public comments. In particular, seven Clinical Subcommittees, composed of a total of 147 members affiliated with 98 professional societies, have provided detailed clinical input on preliminary measure specifications during in-person and webinar meetings convened between May and August of this year.

Field Testing Activities

The following materials will be released on October 16, 2017:

  1. Confidential Field Test Reports
    The field test reports for group practices and solo practitioners will be distributed through the CMS Enterprise Portal which CMS has used in the past for distributing Quality and Resource Use Reports.

National Provider Calls

In conjunction with field testing activities, National Provider Calls will be held on the dates below. The same content will be covered for both calls. Please click on the links below to register:

These calls will provide information on field testing and include a Q&A session. We will share further details for these calls over the coming weeks.

Thank you for your time and consideration, and we look forward to your participation in field testing activities. If you have any questions, please contact QPPCostMeasureTesting@ketchum.com.

Leave a Reply

Your email address will not be published. Required fields are marked *